Programmed Death Ligand 1 (PD-L1) Expression and its Association with Clinicopathologic Profile in Patients with Non-Small Cell Lung Cancer in a Philippine Tertiary Medical Center

Introduction. The current management of advanced non-small cell lung cancer (NSCLC) includes the characterization of Programmed Death Ligand-1 (PD-L1) expression for potential immune checkpoint inhibitor treatment. There is currently no available data regarding the patterns of PD-L1 expression in NS...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Flora Mae Sta. Ines, Jose Jasper Andal, Rex Michael Santiago, Symonette Sandoval, Daphne Ang
Format:	Artigo
Język:	Inglês
Wydane:	Philippine Society of Pathologists, Inc. 2021-06-01
Seria:	Philippine Journal of Pathology
Hasła przedmiotowe:	non-small cell lung cancer lung cancer PD-L1 Philippines
Dostęp online:	https://philippinejournalofpathology.org/index.php/PJP/article/view/215
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!